Vaccine manufacturers want to talk to central govt, says CM Kejriwal

The Delhi government has floated a Global Expression of Interest (EOI) for the procurement of vaccines

Kejriwal
Arvind Kejriwal, chief minister of Delhi | File photo
ANI General News
2 min read Last Updated : May 29 2021 | 5:03 PM IST

As the Delhi government has rolled out global tenders for procuring COVID-19 vaccines, Delhi Chief Minster Arvind Kejriwal has expressed his apprehensions regarding the procurement process, saying that most of the vaccine manufacturers globally prefers to talk only with the central government.

After inaugurating the drive-through vaccination centre in Chhatrasaal Stadium at Model Town today, Arvind Kejriwal said, "We have rolled out global tenders. All our efforts are on but other states that went for global tending so far did not receive encouraging results."

However, Chief Minister in furtherance added, "We have floated the tendering and are hopeful, it will be great if any company do come to us. But I think most of the renowned vaccine manufacturers in the world want to talk to the central government. Let's see how successful state government becomes."

The Delhi government has floated a Global Expression of Interest (EOI) for the procurement of 1 crore doses of Covid-19 vaccines on an urgent basis.

In the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authority of the government of India.

The Delhi government will accept an offer or expression of interest through e-mail by 5 pm on June 7. The efforts are part of efforts to ramp up the vaccination drive against Covid-19.

According to the latest bulletin by Delhi government 1141 positive cases, 71853 Tests conducted, 139 deaths were reported have been reported in the last 24 hours.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: May 29 2021 | 4:54 PM IST

Next Story